Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease

Gastroenterology. 2020 Jun;158(8):2069-2071. doi: 10.1053/j.gastro.2020.01.017. Epub 2020 Jan 13.

Authors

Moshe Loebenstein¹, Julien D Schulberg²

Affiliations

¹ Department of Gastroenterology, St Vincent's Hospital, Melbourne, Australia.
² Department of Gastroenterology, St Vincent's Hospital, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia. Electronic address: [email protected].

PMID: 31945355
DOI: 10.1053/j.gastro.2020.01.017

No abstract available

Publication types

Case Reports

MeSH terms

Adalimumab / administration & dosage
Crohn Disease / diagnosis
Crohn Disease / drug therapy*
Crohn Disease / immunology
Drug Substitution*
Humans
Infliximab / administration & dosage
Infliximab / adverse effects*
Lupus Erythematosus, Systemic / chemically induced*
Lupus Erythematosus, Systemic / diagnosis
Lupus Erythematosus, Systemic / immunology
Male
Middle Aged
Sigmoidoscopy
Symptom Flare Up
Tumor Necrosis Factor Inhibitors / adverse effects*

Substances

Tumor Necrosis Factor Inhibitors
Infliximab
Adalimumab